VARIOUS BRANEMARK SYSTEM IMPLANTS-IMMEDIATE FUNCTION INDICATION

K022562 · Nobel Biocare AB · DZE · Oct 11, 2002 · Dental

Device Facts

• Record ID: K022562
• Device Name: VARIOUS BRANEMARK SYSTEM IMPLANTS-IMMEDIATE FUNCTION INDICATION
• Applicant: Nobel Biocare AB
• Product Code: DZE · Dental
• Decision Date: Oct 11, 2002
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 872.3640
• Device Class: Class 2
• Attributes: Therapeutic

Indications for Use

The Brånemark System implants are for single-stage or two-stage surgical procedures and cement or screw retained restorations. The Branemark System implants are intended for immediate placement and function on single tooth and/or multiple tooth applications recognizing sufficient bone stability (type I or II bone) and appropriate occlusal loading, to restore chewing function. Multiple tooth applications may be splinted with a bar.

Device Story

Brånemark System implants are threaded, root-form dental implants; fabricated from commercially pure titanium; available with machined or TiUnite surface. Used by dental professionals in clinical settings for surgical implantation into jawbone. Device serves as anchorage for dental restorations (cement or screw-retained) to restore chewing function. Supports immediate placement and function protocols when bone stability (type I or II) and occlusal loading conditions are met. Benefits patient by providing stable foundation for prosthetic teeth.

Clinical Evidence

Clinical results provided to support the expanded indications for use for immediate function. No specific sample sizes or statistical metrics (p-values, CIs) reported in the summary document.

Technological Characteristics

Threaded, root-form dental implants; material: commercially pure titanium; surface: machined or TiUnite; classification: Class III; regulation: 21 CFR 872.3640.

Indications for Use

Indicated for patients requiring single or multiple tooth replacement via single-stage or two-stage surgical procedures. Suitable for immediate placement and function in type I or II bone with appropriate occlusal loading. Multiple tooth applications may be splinted with a bar.

Regulatory Classification

Identification

An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.

Special Controls

*Classification.* (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2) *Classification.* Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use; (ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads; (iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system; (iv) The device must be demonstrated to be biocompatible; (v) Sterility testing must demonstrate the sterility of the device; (vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment; (vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians; (viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and (ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.

Submission Summary (Full Text)

{0}------------------------------------------------

K022562

Section 1.7

OCT 11 2002

## 510(k) Summary

| Establishment Information | Nobel Biocare AB<br>15 Bohusgatan<br>P.O. Box 5190<br>Goteborg, Sweden S-402 26<br>Phone: [phone], ext 5073<br>Fax: [phone] |
|---------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact | Kathleen Dragovich<br>Regulatory Affairs Specialist<br>[phone], ext. 7834 |
| Proprietary Device Name | Various Brånemark System Dental Implant Products |
| Classification Name | Endosseous Dental Implant (21 CFR 872.3640) |
| Device Classification | Class III |
| Statement | The information supporting claims of substantial equivalence, as defined under the Federal Food, Drug, and Cosmetic Act, respecting safety and effectiveness is summarized below. |
| Device Description | The Brånemark System implant products that are the subject of this 510(k) are threaded, root-form implants fabricated from commercially pure titanium, either machined or modified (TiUnite) surface, and are already commercially available. |
| Intended Use | The intended use of the Brånemark System Implants is for restoring chewing function by serving as anchorage for dental restorations. |

{1}------------------------------------------------

| Indications<br>for Use | The Brånemark System implants are for single-stage or two-stage<br>surgical procedures and cement or screw retained restorations. The<br>Brånemark System implants are intended for immediate placement<br>and function on single tooth and/or multiple tooth applications<br>recognizing sufficient bone stability (type I or II bone) and<br>appropriate occlusal loading, to restore chewing function. Multiple<br>tooth applications may be splinted with a bar. |
|----------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Technological<br>Characteristics | The technological characteristics of the Brånemark System implants<br>remain substantially unchanged. No design modifications were made<br>that effect safety and effectiveness. |
| Performance<br>Data | Clinical results show that the expanded Indications for Use are as safe<br>and effective as the original Indications for Use. |
| Conclusion | Based on the 510(k) summaries, 510(k) statements and the<br>information provided herein, we conclude that the expanded<br>Indications for Use are substantially equivalent to the currently<br>marketed devices under the Federal Food, Drug, and Cosmetic Act. |

{2}------------------------------------------------

Image /page/2/Picture/1 description: The image shows the seal of the U.S. Department of Health & Human Services. The seal is circular and contains the department's name around the perimeter. In the center of the seal is an abstract image of three human profiles.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Nobel Biocare AB Ms. Kathleen Dragovich Regulatory Affairs Specialist Nobel Biocare USA, Incorporated 22715 Savi Ranch Parkway Yorba Linda, California 92887

## OCT 11 2002

Re: K022562

Trade/Device Name: Various Brânemark System Implants-Immediate Function Indication Regulation Number: 21 CFR 872.3640 Regulation Name: Endosseous Dental Implant Regulatory Class: III Product Code: 76 DZE Dated: July 30, 2002 Received: August 2, 2002

Dear Ms. Dragovich:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{3}------------------------------------------------

Page 2 - Ms. Dragovich

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at [phone]. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.qov/cdrh/dsma/dsmamain.html

Sincerely vours.

Patricia Cicciotte

Timothy A. Ulatowski Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

K022562

Section 1.5

Indications for Use Statement

Page 1 of 1

510(k) Number (if known):

Not yet assigned

Device Name:

Various Brånemark System Implants -Immediate Function Indication

Indications for Use:

The Brånemark System implants are for single-stage or two-stage surgical procedures and cement or screw retained restorations. The Branemark System implants are intended for immediate placement and function on single tooth and/or multiple tooth applications recognizing sufficient bone stability (type I or II bone) and appropriate occlusal loading, to restore chewing function. Multiple tooth applications may be splinted with a bar.

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDHR, Office of Device Evaluation (ODE)

Prescription Use (per 21 CFR 801.109) OR

Over-the-Counter Use Optional Format 1-2-96

Robert S. Betz, DDS for Dr. Susan Rummer

General Hospital.

510(k) Number: K022562

July 2002